secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2026-07-02T20:00:46+00:00
Accession:  0001493152-26-031870
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte completes merger with NOMAD, changes name to Nomad Power Solutions, ticker to NMAD
--------------------------------------------------------------------------------

- Merger closed July 1, 2026; NOMAD becomes wholly owned subsidiary of Lixte.
- Consideration: 2,992,041 common shares and 50,366.07 Series D preferred shares (convertible into 50,366,070 common shares at $1.00/share).
- Company name changes to Nomad Power Solutions effective July 3, 2026; ticker changes to NMAD on July 6, 2026.
- John Travaglini appointed to board; continues as NOMAD CEO.
- NOMAD has over 30 active projects across North America; addresses multi-billion-dollar market for mobile BESS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226031870/0001493152-26-031870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226031870/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-031870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer